EDP Biotech Detects Early Stage Colon Cancer

Identification and detection of new biomarkers that identify the beginning stages of diseases is critical for achieving successful medical treatment. EDP Biotech Corporation is a medical device company that is developing a sophisticated technological platform for detecting early stage colon cancer from minimal patient blood samples, enabling early diagnosis, in a timely and cost effective manner. This technology is poised to transform colon cancer patient screening to a simple blood test that saves both time and money, as well as vastly improves patient compliance and prognosis, since current methodologies are more invasive and have a significantly lower detection rate.

Leave a Reply

Your email address will not be published.